Inherited Nucleotide Repeat Disorder Dna Test
The Inherited Nucleotide Repeat Disorder DNA Test is a prescription in vitro diagnostic test designed to detect and identify the number of nucleotide repeats in a gene using genomic DNA isolated from post-natal patient specimens, intended as an aid for carrier testing and diagnosis of inherited nucleotide repeat-associated disorders (such as Huntington's disease or fragile X syndrome), to be used in conjunction with other clinical and diagnostic findings. It is classified as Class 2 (FDA Class 2), requiring 510(k) premarket clearance. The product code is OYV, with regulation number 866.5970 under the Immunology specialty, reviewed by the pathology panel.
Basic Information
- Product Code
- OYV
- Device Class
- FDA class 2
- Regulation Number
- 866.5970
- Medical Specialty
- Immunology
- Review Panel
- PA
- Submission Type
- 1
Device Characteristics
Definition
An inherited nucleotide repeat disorder DNA test is a prescription in vitro diagnostic test that is intended to detect and identify the number of nucleotide repeats in a gene using genomic DNA isolated from post-natal patient specimens. It is solely intended as an aid for carrier testing and as an aid for the diagnosis of inherited nucleotide repeat-associated disorders. Assay results are solely intended to be used in conjunction with other clinical and diagnostic findings. These tests do not include those indicated for use for fetal diagnostic testing or newborn screening.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| DEN190023 | AmplideX Fragile X Dx & Carrier Screen Kit | Feb 21, 2020 | Unknown | Asuragen, Inc. |
FEI Numbers
This FDA classification entry is associated with 1 FEI number. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 1 registration number. Click on an entry to view related FDA registrations.